Microbix Collaborator Introduces New Lab Accreditation Program - Seite 3

Forward-Looking Information
This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Labquality or its EQA schemes, the Poster, the Mgen QAPs, or their relevance, Microbix’s or others’ products or services, business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced in its presentations, regulatory compliance and approvals, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity or timeliness of delivery), currency exchange rates, maintaining adequate working capital or raising new capital on acceptable terms or at all, and other similar statements about anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions, and expectations; they are not guarantees of future performance. Microbix cautions that all forward-looking information is inherently uncertain and actual performance may be affected by many material factors, some of which are beyond its control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions, and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent Microbix’s judgement as of the date of this new release, and it is under no obligation to update or alter any forward-looking information.

Please visit https://microbix.com or https://www.sedarplus.ca for recent Microbix news and filings.

For further information, please contact Microbix at:

Cameron Groome, CEO [phone]

Jim Currie, CFO [phone]

Deborah Honig, Investor Relations Adelaide Capital Markets [phone] [e-mail]

Copyright 2024 Microbix Biosystems Inc.
Microbix, DxTM, Kinlytic, PROCEEDx, QAPs, and REDx are trademarks of Microbix Biosystems Inc.
PROCEEDxFLOQ and REDxFLOQ are trademarks of Microbix Biosystems Inc. in collaboration with Copan Italia S.p.A.
Copan, FLOQ, and FLOQSwab are trademarks of Copan Italia S.p.A.
Other companies’ names and products are protected by their respective trademarks.